Our goal is to provide compassionate, evidence-based care that addresses the underlying factors contributing to weight gain while helping patients build sustainable, healthy habits
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohns disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
In hypertension models, GLP-1 RAs exert beneficial effects through multiple mechanisms including vascular vasodilation, diuresis, decreased sympathetic activity in the central nervous system, and reduced blood pressure variability (BPV) [15]
There is growing interest in targeted interventions in that field
If the cut-off for deficiency is set higher, you diagnose more people who have deficiency, but you also end up treating more people who dont have a deficiency